Your browser doesn't support javascript.
In-Hospital Cardiac Arrest (IHCA) and Outcomes in Patients Admitted With COVID-19 Infection.
Khosla, Rahul; Delio, Joseph; Glass, Lisa N; Khosla, Shikha G; Awan, Omar; Bawa, Amandeep; Vyas, Kavita.
  • Khosla R; Pulmonary and Critical Care Medicine, Veterans Affairs Medical Center, Washington, USA.
  • Delio J; Pulmonary and Critical Care Medicine, The George Washington University School of Medicine and Health Sciences, Washington, USA.
  • Glass LN; Pulmonary and Critical Care Medicine, The George Washington University School of Medicine and Health Sciences, Washington, USA.
  • Khosla SG; Endocrinology, Diabetes and Metabolism, Veterans Affairs Medical Center, Washington, USA.
  • Awan O; Pulmonary and Critical Care Medicine, Veterans Affairs Medical Center, Washington, USA.
  • Bawa A; Pulmonary and Critical Care Medicine, Veterans Affairs Medical Center, Washington, USA.
  • Vyas K; Pulmonary and Critical Care Medicine, The George Washington University School of Medicine and Health Sciences, Washington, USA.
Cureus ; 13(6): e15365, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1270243
ABSTRACT
During the COVID-19 pandemic, many patients are hospitalized, and those suffering from in-hospital cardiac arrest (IHCA) have been previously reported to have poor outcomes. This is a single-center, retrospective, observational study conducted at the Veterans Affairs Medical Center, Washington, DC, USA. The inclusion criteria were patients admitted to the hospital with a diagnosis of COVID-19 who underwent cardiopulmonary resuscitation (CPR) for IHCA. Patients were labeled as COVID-19 positive based on a laboratory-confirmed positive polymerase chain reaction test. Patients with do-not-resuscitate (DNR) orders, those who were made comfort care, or enrolled in hospice were excluded. The study was approved by the hospital's institutional review board. A total of 155 patients with COVID-19 infection were admitted; 145/155 (93.5%) admitted to the medical floor and 10/155 (6.5%) to the medical intensive care unit (MICU). 36/145 (24.8%) floor patients were upgraded to MICU. Of the 46 patients treated in MICU, 17/46 (36.9%) were excluded for DNR status. From the remaining 29/46 (63.1%) patients, 19/29 (65.5%) patients survived, and 10/29 (34.5%) patients had IHCA. All 10/10 (100%) died after CPR without return of spontaneous circulation (ROSC). The initial rhythm was non-shockable in all patients, with pulseless electrical activity (PEA) in 7/10 (70%) and asystole in 3/10 (30%) patients. Patients with COVID-19 infection who had an IHCA and underwent CPR had a 0% survival at our hospital. Discussions on advanced care options, especially CPR, with COVID-19 patients and their families, are important as the overall prognosis after CPR for IHCA is poor.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Cureus Year: 2021 Document Type: Article Affiliation country: Cureus.15365

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Cureus Year: 2021 Document Type: Article Affiliation country: Cureus.15365